[1] Johnson KJ. and Weinberg JM. Postischemic renal injury due to oxygen radicals. Curr Opin Nephrol Hypertens 2: 625–635, 1993.
[2] Kim J, Kim KY, Jang HS, Yoshida T, Tsuchiya K, Nitta K, Park JW, Bonventre JV, and Park KM. Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 296: F622–F633, 2009.
[3] Sang Jun Han1, Jee In Kim, Jeen-Woo Park and Kwon Moo Park. Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury. Nephrol Dial Transplant (2015) 30: 1497–1506.
[4] Baolong Q, Qing W, Yuchao L, et al. Losartan Ameliorates Calcium Oxalate-Induced Elevation of Stone-Related Proteins in Renal Tubular Cells by Inhibiting NADPH Oxidase and Oxidative Stress[J]. Oxidative Medicine and Cellular Longevity, 2018, 2018: 1-12.
[5] Li J J, Tang Q, Li Y, et al. Role of oxidative stress in the apoptosis of. hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid[J]. Acta Pharmacologica Sinica, 2010, 27(8):1078-1084.
[6] Babior BM. The respiratory burst oxidase [J]. CurrOpinHematol, 1995, 2(1):55-60.
[7] Lambeth JD, Cheng G, Arnold RS, etal. Novel homologs of gp91 phox [J]. Trends. Biochem Sci, 2000, 25(10):459-461.
[8] Sawhney S, Fraser SD. Epidemiology of AKI: utilizing large databases to determine. the burden of AKI. Adv Chronic Kidney Dis. 2017; 24:194–204.
[9] Sawhney S., Marks A., Fluck N., Levin A., Prescott G.J., Black C. Intermediate and. long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study. Am J Kidney Dis. 2017;69(1):18–28.
[10] Chertow G.M., Burdick E., Honour M., Bonventre J.V., Bates D.W. Acute kidney. injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370.
[11] Rifkin D.E., Coca S.G., Kalantar-Zadeh K. Does AKI truly lead to CKD? J Am Soc Nephrol. 2012;23(6):979–984.
[12] Hsu CY. Yes, AKI truly leads to CKD. J Am Soc Nephrol. 2012;23(6):967–969.
[13] Siew ED, Davenport A. The growth of acute kidney injury: a rising tide or just. closer attention to detail? Kidney Int. 2015;87(1):46-61.
[14] Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005; 365(9457): 417-430.
[15] Miller TW, Wang EA, Gould S, et al. Hydrogen sulfide is an endogenous. potentiator of T cell activation[J]. J Biol Chem, 2012, 287(6): 4211-4221.
[16] Fransen M, Nordgren M, Wang B, et al. Role of peroxisomes in ROS/RNS-metabolism: implications for human disease[J]. Biochim Biophys Acta, 2012, 1822(9): 1363-1373.
[17] Liao F, Zheng Y, Geng B. Hydrogen sulfide - a new cardioprotective factor [J]. Progress in physiological science, 2012, 43(2): 111-114.
[18] Tang XQ, Yang CT, Feng JQ. Research progress on the neuroprotective effect of. the third gas signal molecule hydrogen sulfide[J]. Medical Sciences Journal of Central South China, 2012, 40(1):1-5.
[19] Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial Reactive Oxygen Species. (ROS) and ROS-Induced ROS Release. Physiol. Rev. 2014; 94: 909–950. doi: 10.1152/physrev.00026.2013.
[20] Tarafdar A, Pula G. The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders[J]. International Journal of Molecular Sciences, 2018, 19(12).
[21] Radermacher K A, Wingler K, Kleikers P, et al. The 1027th target candidate in stroke: Will NADPH oxidase hold up? [J]. Experimental & Translational Stroke Medicine,4,1(2012-05-24), 2012, 4(1).
[22] Kleikers PW, Wingler K, Hermans JJ, Diebold I, Altenhöfer S, Radermacher KA, Janssen B, Görlach A, Schmidt HH. NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury. J Mol Med (Berl). 2012,90(12):1391-406.
[23] Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245–313.
[24] Bedard K, Lardy B, Krause KH. NOX family NADPH oxidases: not just in. mammals. Biochimie 2007, 89:1107–1112.
[25] Opitz N, Drummond GR, Selemidis S, Meurer S, Schmidt HH. The 'A's and 'O's. of NADPH oxidase regulation: a commentary on "Subcellular localization and function of alternatively spliced Noxo1 isoforms". Free Radic Biol Med 2007, 42:175–179.
[26] Lambeth JD. NOX enzymes, ROS, and chronic disease: an example of antagonistic. pleiotropy. Free Radic Biol Med. 2007;43(3):332-347.
[27] Muzaffar S, Jeremy JY, Sparatore A, Del Soldato P, Angelini GD, Shukla N. H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br J Pharmacol. 2008 ;155(7):984-94.
[28] Wang R. Two’s company, there’s acrowd: Can H2S be the third endogenous. gaseous transmitter. FASEB J,2002 16(13):1792-1798.
[29] Xu Z, Prathapasinghe G, Wu N, Hwang SY, Siow YL, OK. Ischemia-reperfusion. reduces cystathionine-beta-synthase-mediated hydrogen sulfide generation in the kidney. Am J Physiol Renal Physiol. 2009 ;297(1): F27-35.